News
LTRN
1.220
+0.83%
0.010
New to The Street Show 773 Premieres Tonight on Bloomberg Television, Featuring Glint, Sagtec Global, BioVie and SafeSpace Global
Barchart · 1d ago
Lantern Pharma Highlights Open-Medicine AI Oncology Platform
TipRanks · 2d ago
Lantern Pharma Showcases Open-Medicine AI Growth Strategy
TipRanks · 3d ago
Open-Medicine AI: Lantern Pharma to Present the Agentic AI Drug Development Market, User Needs, Development Roadmap, Platform Economics, and Benchmarks, Today at 12:30 PM ET
Barchart · 4d ago
Lantern Pharma secures USPTO notice of allowance for LP-284 patent
TipRanks · 4d ago
Lantern Pharma Issued Notice Of Allowance From U.S. Patent And Trademark Office For Application Titled Method For Treating Blood Cancers
Benzinga · 4d ago
Lantern Pharma Secures USPTO Notice of Allowance for LP‑284 Treatment Patent in Aggressive B‑Cell Lymphomas
Barchart · 5d ago
Weekly Report: what happened at LTRN last week (0914-0918)?
Weekly Report · 6d ago
New to The Street Broadcasts Tonight at 6:30 PM ET Across the United States, Latin America and MENA, Featuring BioVie, Acurx Pharmaceuticals, Lantern Pharma and SafeSpace Global
Barchart · 09/19 10:45
Lantern Pharma Q2 2026 Earnings Call: Complete Transcript
Benzinga · 09/18 12:47
Lantern Pharma to host webinar on Open-Medicine AI
TipRanks · 09/17 12:25
Lantern Pharma to Present Open-Medicine AI — a Multi-Agentic Platform for End-to-End Therapeutic Development — Business Model, Roadmap, and Value Proposition on September 23
Barchart · 09/17 07:20
Weekly Report: what happened at LTRN last week (0907-0911)?
Weekly Report · 09/14 09:15
New to The Street Show 771 Airs Today on Bloomberg, Featuring Bill Mobley, Panna Sharma, Phillip Toppino and Dr. Kelley Gurley
Barchart · 09/12 09:35
Weekly Report: what happened at LTRN last week (0831-0904)?
Weekly Report · 09/07 09:14
New to The Street Broadcasts at 6:30 PM ET Across Bloomberg U.S., Latin America and MENA, Featuring Lantern Pharma (NASDAQ:LTRN), SafeSpace Global (OTCID:SSGC) and FreeCast (NASDAQ:CAST)
Barchart · 09/05 09:50
Weekly Report: what happened at LTRN last week (0824-0828)?
Weekly Report · 08/31 09:15
New to The Street Broadcasting Today at 6:30 PM EST on Bloomberg Television Across the U.S., Latin America and MENA-Featuring FreeCast (NASDAQ: CAST), Metaterra Holdings (MTHI) and SafeSpace Global (SGCC)
Barchart · 08/29 08:20
Lantern Pharma Earnings Call: AI Spinout, Trial Momentum
TipRanks · 08/25 00:22
Weekly Report: what happened at LTRN last week (0817-0821)?
Weekly Report · 08/24 09:15
More
Webull provides a variety of real-time LTRN stock news. You can receive the latest news about Lantern Pharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About LTRN
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 200 billion oncology-focused data points and a library of 200+ ML algorithms. It is engaged in the development of its pipeline of drug candidates that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate program. Its portfolio includes a Phase II clinical program (LP-300) in NSCLC focused on never-smokers and non-smokers with the EGFR exon 21 L858R mutation; planned Phase I b/II trials (LP-184) in precision, biomarker-defined solid tumors, and an ongoing Phase II program in hematologic malignancies and adult soft tissue sarcomas (LP-284). It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.